BRU •
Healthcare •
Biotechnology •
Quote as of 06/12/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeBRU
Market Capitalization0.3331 mln
Float76.83 mln
Earnings Date04/11/2025
Piotroski F-Score
3
/ 9
Below average
Beneish M-Score
151
Highly suspicious
Relative Strength
2
/ 100
Severely lagging
Debt / Equity
-0.89
Negative equity
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Business Description
Based in Leuven, Belgium, Oxurion NV is a medical research company focused on protecting the eyesight of people living with serious retinal conditions, such as age-related macular degeneration and geographic atrophy. Founded in 1991 and previously called ThromboGenics NV, the company works to bring new treatments to patients at risk of losing their vision.
